Although Australia’s biotechnology industry is relatively young, the sector has enjoyed significant growth in recent years. This is fuelled by a commitment by both Federal and State Governments to foster a world-class culture of innovation and a robust R&D infrastructure. There is also a strong push to commercialise research emerging from university departments and other publicly funded research agencies.
Consequently Australia has a significant number of stem cell-based products already in clinical development.